Ignite Creation Date:
2024-05-06 @ 6:52 PM
Last Modification Date:
2024-10-26 @ 2:56 PM
Study NCT ID:
NCT05815927
Status:
NOT_YET_RECRUITING
Last Update Posted:
2024-02-22
First Post:
2023-03-13
Brief Title:
Pembrolizumab and Radiotherapy for Oligometastatic Head and Neck Cancer
Sponsor:
European Organisation for Research and Treatment of Cancer - EORTC
Organization:
European Organisation for Research and Treatment of Cancer - EORTC
Key Dates - Follows AllAPIJSON File Order
Start Date:
2024-06-15
Start Date Type:
ESTIMATED
Primary Completion Date:
2027-07-15
Primary Completion Date Type:
ESTIMATED
Completion Date:
2030-03-30
Completion Date Type:
ESTIMATED
First Submit Date:
2023-03-13
First Submit QC Date:
April 14 2023
Study First Post Date:
2023-04-18
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-02-21
Last Update Post Date:
2024-02-22
Last Update Post Date Type:
ACTUAL